Graves' animal models of Graves' hyperthyroidism

Thyroid

Volumn 17, Issue 10, 2007, Pages 981-988

  Nagayama, Yuji ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RITUXIMAB; THYROTROPIN RECEPTOR;

AUTOIMMUNITY; DISEASE MODEL; DISEASE PREDISPOSITION; EFFECTOR CELL; EYE DISEASE; GRAVES DISEASE; HEREDITY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ANIMALS; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GRAVES DISEASE; IMMUNE TOLERANCE; MICE; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES, REGULATORY;

EID: 35948994513     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2007.0161     Document Type: Review

References (88)

1. Adams DD, Purves HD 1956 Abnormal responses in the assay of thyrotropin. Proc Univ Otago Med Sch 34:11-12.
2. Meek JC, Jones AE, Lewis UJ, Vanderlaan WP 1964 Characterization of the long-acting thyroid stimulator of Graves' disease. Proc Natl Acad Sci USA 52:342-349.
3. Kriss JP, Pleshakov V, Chien JR 1964 Isolation and identification of the long-acting thyroid stimulator and its relation to hyperthyroidism and circumscribed pretibial myxedema. J Clin Endocrinol Metab 24:1005-1028.
4. Rees Smith B, Hall R 1974 Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 2:427-431.
5. Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K 1978 Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 46:734-739.
6. Rose NR, Witebsky E 1956 Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts. J Immunol 76:417-427.
7. Shimojo N, Kohno Y, Yamaguchi K, Kikuoka S, Hoshioka A, Niimi H, Hirai A, Tamura Y, Saito Y, Kohn LD, Tahara K 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 93:11074-11079.
8. McLachlan SM, Nagayama Y, Rapoport B 2005 Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26:800-832.
9. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19:673-716.
10. Kaithamana S, Fan J, Osuga Y, Liang S-G, Prabhakar BS 1999 Induction of experimental autoimmune Graves' disease in BALB/c mice. J Immunol 163:5157-5164.
11. Costagliola S, Many M-C, Dehef J-F, Pohlenz J, Refetoff S, Vassart G 2000 Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 105:803-811.
12. Nagayama Y, Kita-Furuyama M, Nakao K, Ando T, Mizuguchi H, Hayakawa T, Eguchi K, Niwa M 2002 A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing thyrotropin receptor. J Immunol 168:2789-2794.
13. Kita-Furuyama M, Nagayama Y, Pichurin P, McLachlan SM, Rapoport B, Eguchi K 2003 Dendritic cells infected with adenovirus expressing the thyrotropin receptor induce Graves' hyperthyroidism in BALB/c mice. Clin Exp Immunol 131:234-240.
14. Kaneda T, Honda A, Hakozaki A, Fuse T, Muto A, Yoshida T 2007 An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB/c mice. Endocrinology 148:2335-2344.
15. Kim-Saijo M, Akamizu T, Ikuta K, Iida Y, Ohmori K, Matsubara K, Matsuda Y, Suzuki M, Matsuda F, Nakao K 2003 Generation of transgenic animal model of hyperthyroid Graves' disease. Eur J Immunol 33:2531-2538.
16. Ree Smith B, McLachlan SM, Furmaniak J 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev 9:106-121.
17. Chazenbalk GD, Pichurin P, Chen CR, Latrofa F, Johnstone AP, McLachlan SM, Rapoport B 2002 Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. J Clin Invest 110:209-217.
18. Chen C-R, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves' disease is the culprit as well as the victim. J Clin Invest 111:1897-1904.
19. Mizutori Y, Saitoh O, Eguchi K, Nagayama Y 2006 Adenovirus coding the thyrotropin receptor A subunit improves the efficacy of dendritic cell-based mouse model of Graves' hyperthyroidism. J Autoimmun 26:32-36.
20. Pichurin PN, Chen C-R, Nagayama Y, Pichurin O, Rapoport B, McLachlan SM 2004 Evidence that factors other than particular thyrotropin receptor T cell epitopes contribute to the development of hyperthyroidism in murine Graves' disease. Clin Exp Immunol 135:391-397.
21. Chazenbalk GD, Latrofa F, McLachlan SM, Rapoport B 2004 Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. J Clin Endocrinol Metab 89:1788-1793.
22. Sanders J, Bolton J, sanders P, Jeffreys J, Nakatake N, Richard T, Evans M, Kiddie A, Summerhayes S, Roberts E, Miguel RN, Furmaniak J, Rees Smith B 2006 Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16:1195-1206.
23. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S, Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18:3020-3034.
24. Baker G, Mazziotti M, von Ruhland C, Ludgate M 2005 Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy. Endocrinology 146:835-844.
25. Rao PV, Watson PF, Weetman AP, Carayanniotis G, Banga JP 2003 Contrasting activities of thyrotropin receptor antibodies in experimental models of Graves' disease induced by injection of transfected fibroblasts or deoxyribonucleic acid vaccination. Endocrinology 144:260-266.
26. Pichurin P, Yan X-M, Farilla L, Guo J, Chazenbalk GD, Rapoport B, McLachlan SM 2001 Naked TSH receptor DNA vaccination: a Th1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice. Endocrinology 142:3530-3536.
27. Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, Kumahara Y 1978 Association of serum antithyroid antibodies with lymphocyte infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab 46:859-862.
28. Paschke R, Vogg M, Swillens S, Usadel KH 1993 Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease. J Clin Endocrinol Metab 77:939-943.
29. McLachlan SM, Braley-Mullen H, Chen C-R, Aliesky H, Pichurin PN, Rapoport B 2005 Dissociation between iodide-induced thyroiditis and antibody-mediated hyperthyroidism in NOD.H-2h4 mice. Endocrinology 146:294-300.
30. Bahn RS 2003 Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88:1939-1946.
31. Rapoport B, Alsabeh R, Aftergood D, McLachlan SM 2000 Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease Thyroid 10:685-692.
32. Chen C-R, Abbud R, Wang C, Tan Y, Rapoport B, McLachlan SM 2005 Gene expression profiles differ markedly in mouse strains that are (or are not) susceptible to hyperthyroidism induced using thyrotropin receptor-expressing adenovirus. Thyroid 15:1229-1237.
33. Nagayama Y, McLachlan SM, Rapoport B, Niwa M 2003 A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism. Thyroid 13:235-240.
34. Pichurin P, Chen C-R, Pichurin O, David C, Rapoport B, McLachlan SM 2003 Thyrotropin receptor-DNA vaccination of transgenic mice expressing HLA-DR3 or HLA-DQ6b. Thyroid 13:911-917.
35. Aliesky HA, Pichurin PN, Chen C-R, Williams RW, Rapoport B, McLachlan SM 2006 Probing the genetic basis for thyrotropin receptor antibodies and hyperthyroidism in immunized CXB recombinant inbred mice. Endocrinology 147:2789-2800.
36. Seetharamaiah GS, Land KJ 2006 Differential susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism. Thyroid 16:651-658.
37. Su MA, Anderson MS 2004 Aire: an update. Curr Opin Immunol 16:746-752.
38. Pichurin P, Pichurina O, Marians RC, Chen C-R, Davies TF, Rapoport B, McLachlan SM 2004 Thyrotropin receptor knockout mice: studies on immunological tolerance to a major thyroid autoantigen. Endocrinology 145:1294-1301.
39. Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, Iriuchijima T, Yokoo H, Yoshida I, Tsushima Y, Mori M 1996 Thymic hyperplasia in patients with Graves' disease: identification of thyrotropin receptors in human thymus. J Clin Invest 98:2228-2234.
40. Murakami M, Hosoi Y, Araki O, Morimura T, Imamura M, Ogiwara T, Mizuma H, Mori M 2001 Expression of thyrotropin receptors in rat thymus. Life Sci 68:2781-2787.
41. Pichurin PN, Chen C-R, Chazenbalk GD, Aliesky H, Pham N, Rapoport B, McLachlan SM 2006 Targeted expression of the human thyrotropin receptor A-subunit to the mouse thyroid: insight into overcoming the lack of response to A-subunit adenovirus immunization. J Immunol 176:668-676.
42. Liston A, Gray DHD, Lesage S, Fletcher AL, Wilson J, Webster KE, Scott HS, Boyd RL, Peltonen L, Goodnow CC 2004 Gene dosage-limiting role of aire in thymic expression, clonal deletion and organ-specific autoimmunity. J Exp Med 200:1015-1026.
43. Akkaraju S, Ho WY, Leoong D, Canaan K, Davis MM, Goodnow CC 1997 A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7:255-271.
44. McLachlan SM, Pichurin PN, Nagayama Y, Aliesky HA, Chen CR, Rapoport B 2006 Tolerance, regulatory T cells and autoimmunity to the thyrotropin receptor: insight from transgenic mice expressing the human TSHR A-subunit in the thyroid. Abstract in the annual meeting of the 77th American Thyroid Association.
45. + regulatory T cells in a mouse model. Endocrinology 147:2417-2422.
46. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-352.
47. Beissert S, Schwartz A, Schwartz T 2006 Regulatory T cells. J Invest Dermatol 126:15-24.
48. Nagayama Y, Niwa M, McLachlan SM, Rapoport B 2004 Schistosoma mansoni and α-galactosylceramide: prophylactic effect of Th1 immune suppression in a mouse model of Graves' hyperthyroidism. J Immunol 173:2167-2173.
49. + regulatory T cell-depleted mice. Cancer Res 65:8471-8478.
50. Wei WZ, Morris GP, Kong YM 2004 Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells. Cancer Immunol Immunother 53:73-78.
51. + T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170:5511-5522.
52. + T cells. J Immunol 174:7433-7439.
53. + regulatory T cell homeostasis and prevention of thyroiditis. J Immunol 172:787-794.
54. + medullary thymic epithelial cells. Nat Immunol 8:351-358.
55. + T cells in the maintenance of T cell homeostasis. J Exp Med 200:1123-1134.
56. + T cells. J Immunol 175:7093-7097.
57. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N, de la Fuente H, Alvarado-Sanchez B, Monsivais-Urenda A, Sanchez-Madrid F, Gonzalez-Amaro R 2006 Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91:3639-3634.
58. + regulatory T cells in autoimmune thyroid diseases. Thyroid 17:25-31.
59. + regulatory T cells in the steady state. J Exp Med 198:737-746.
60. + T cells. J Clin Invest 112:1437-1443.
61. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971-979.
62. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199:1285-1291.
63. Chazenbalk GD, Pichurin PN, Guo J, Rapoport B, McLachlan MC 2005 Interactions between the mannose receptor and thyroid autoantigens. Clin Exp Immunol 139:216-224.
64. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969-1980.
65. Seddon B, Mason D 1999 Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 189:877-882.
66. Samy ET, Setiady YY, Ohno K, Pramoonjago P, Sharp C, Tung KS 2006 The role of physiological self-antigen in the acquisition of and maintenance of regulatory T-cell function. Immunol Rev 212:170-184.
67. Suri-Payer E, Fritzsching B 2006 Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol 28:3-16.
68. Mosmann TR, Coffman RL 1989 Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
69. Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC Jr, Shine B, Marshall NJ 1990 Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. J Clin Invest 86:723-727.
70. Latrofa F, Chazenbalk GD, Pichurin P, Chen CR, McLachlan SM, Rapoport B 2004 Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. J Clin Endocrinol Metab 89:4734-4745.
71. Kita M, Ahmad L, Marians RC, Vlase H, Unger P, Graves PN, Davies TF 1999 Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology 140:1392-1398.
72. Dogan R-NE, Vasu C, Holterman MJ, Prabhakar BS 2003 Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 170:2195-2204.
73. Land KJ, Moll JS, Kaplan MH, Seetharamaiah GS 2004 Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology 145:3724-3730.
74. Barrett K, Liakata E, Rao PV, Watson PF, Weetman AP, Lymberi P, Banga JP 2004 Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor. Clin Exp Immunol 136:413-422.
75. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B 2003 Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice by IL-4, a Th2 cytokine. J Immunol 170:3522-3527.
76. Aniszewski JP, Valyasevi RW, Bahn RS 2000 Relationship between disease duration and predominant orbital T cell subset in Graves' disease. J Clin Endocrinol Metab 85:776-780.
77. Yan X-M, Guo J, Pichurin P, Tanaka K, Jaume JC, Rapoport B, McLachlan SM 2000 Cytokines, IgG subclasses and costimulation in a mouse model of thyroid autoimmunity induced by injection of fibroblasts co-expressing MHC class II and thyroid autoantigens. Clin Exp Immunol 122:170-179.
78. Land KJ, Gudapati P, Kaplan MH, Seetharamaiah GS 2006 Differential requirement of signal transducer and activator of transcription-4 (Stat4) and Stat6 in a thyrotropin receptor-289-adenovirus-induced model of Graves' hyperthyroidism. Endocrinology 147:111-119.
79. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM 2006 Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24:677-688.
80. Steinman L 2007 A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139-145.
81. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B 2006 TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17 producing T cells. Immunity 24:179-189.
82. Saitoh O, Mizutori Y, Takamura N, Yamasaki H, Kita A, Kuwahara H, Nagayama Y 2005 Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor β, ameliorates the induction of Graves' hyperthyroidism in BLAB/c mice. Clin Exp Immunol 141:405-411.
83. Lenzner C, Morgenthaler NG 2003 The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease. Thyroid 13:1153-1161.
84. Wang SH, Baker JR Jr 2006 Targeting B cells in Graves' disease. Endocrinology 147:4559-4560.
85. Hasselbalch HC 2003 B-cell depletion with rituximab-a targeted therapy for Graves' disease and autoimmune thyroiditis. Immunol Lett 88:85-86.
86. Salvi M, Vannucchi G, Campi I, Curro N, Dazzi D, Simonetta S, Bonara P, Rossi S, Sina C, Guastella C, Ratglia R, Beck-Peccoz P 2007 Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur J Endocrinol 156:33-40.
87. Gilbert JA, Kalled SL, Moorhead J, Hess DM, Rennert P, Li Z, Khan MZ, Banga JP 2006 Treatment of autoimmune hyperthyroidism in a murine model of Graves' disease with tumor necrosis factor-family ligand inhibitors suggests a key role for B cell activating factor in disease pathology. Endocrinology 147:4561-4568.
88. Mestas J, Hughes CCW 2004 Of mice and not men: differences between mouse and human immunology. J Immnuol 172:2731-2738.